It was the patient's dream to become a mother one day, but the existence of a massive fibroid in her uterus was threatening this dream and affecting her health. A timely treatment, however, solved her ...

Previously, fibroids were most commonly diagnosed in women in their 30s-50s but now they can occur at any age. Often, ...

Discover the chronic health complications of uterine fibroids beyond heavy periods, from anemia to fertility concerns, and ...

Fibroid degeneration occurs when a uterine fibroid outgrows its limited blood supply and begins to die. Fibroids are benign uterine growths made of smooth muscle cells and fibrous tissue.

The size and location of the fibroid can influence how quickly it shrinks. Smaller fibroids may regress faster, while larger ones could take longer to shrink. The body’s overall hormone levels ...

Uterine fibroids are one of the most common problems women face during their childbearing years. But finding a solution to ...

The majority of women with uterine fibroids are asymptomatic, consequently get less clinical attention and fibroid tumors often remain undiagnosed. [23,24] Symptomatic women typically complain ...

We spoke to Dr Naveen Chandrashekhar, Consultant Intervention Radiologist, Gleneagles BGS Hospital, Kengeri, Bengaluru, who explained how intervention radiology is revolutionising fibroid ...

Around two-thirds of women will develop at least one uterine fibroid in their lifetime, while one-third will be symptomatic. Black women are roughly two-to-three times more likely to develop UFs ...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.

The Fibroid Foundation Africa is battling a surge in misinformation surrounding uterine fibroids, fuelled significantly by pervasive radio and television advertisements promotion.